Kinaxis Announces Normal Course Issuer Bid

ملخص مفصل

Kinaxis® Inc. announced that the Toronto Stock Exchange has accepted a notice filed by the Company of its intention to make a normal course issuer bid.

Subject to any required regulatory approvals, all purchases of Shares under the NCIB will be conducted through the facilities of the TSX and/or alternative Canadian trading systems at prevailing market prices, or by such other means as may be permitted by the applicable securities regulators. All Shares purchased under the NCIB will be canceled.

Kinaxis has entered into an ASPP with the Broker to allow for the purchase of Shares under the NCIB at times when the Company would ordinarily not be permitted to purchase Shares due to regulatory restrictions or self-imposed blackout periods.

Pursuant to the ASPP, prior to entering into a blackout period, Kinaxis may, but is not required to, instruct the Broker to make purchases under the NCIB in accordance with the terms of the ASPP. Such purchases will be determined by the Broker in its sole discretion based on parameters established by Kinaxis prior to the blackout period in accordance with the rules of the TSX, applicable securities laws and the terms of the ASPP. The ASPP has been pre-cleared by the TSX concurrently with the initiation of the NCIB.

The board of directors of the Company (the “Board”) believes that, from time to time, the market price of the Shares may not fully reflect the underlying value of the Company’s business. As a result, depending upon future price movements and other factors, the Board believes that the purchase of the Shares would be a desirable use of corporate funds in the best interests of the Company. Furthermore, the purchases are expected to benefit all persons who continue to hold Shares by increasing their equity interest in the Company when such repurchased Shares are canceled.

Under the Previous Bid, which expires on November 11, 2026, the Company received approval from the TSX to purchase for cancellation up to a maximum of 2,799,843 Shares, representing approximately 10% of Kinaxis’ ”public float” as at October 31, 2025.

This press release contains forward-looking information within…

مطلع المقال، مقتطف من BNN Bloomberg. لقراءة المقال كاملًا، افتحه على موقع الناشر.